Johnnie J Orozco

9PUBLICATIONS
58CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 11, 2026
The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy.

Matthew W Hagen, Nicollette J Setiawan, Shannon Dexter

|Jul 03, 2025
Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in Patients with High-risk B-cell Lymphomas.

Johnnie J Orozco, Manuela C Matesan, Sally J Lundberg

|Apr 16, 2025
The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy.

Matthew W Hagen, Nicollette J Setiawan, Shannon Dexter

|Sep 19, 2024
Randomized Phase III SIERRA Trial of 131I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.

Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian

|Nov 08, 2023
Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors.

Johnnie J Orozco, Phuong T Vo, Ted A Gooley

|Jun 20, 2023
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.

Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus

Pageof 2

Frequent Collaborators

5 joint publications

Brenda M Sandmaier

4 joint publications

Damian J Green

4 joint publications

Theodore A Gooley

3 joint publications

Darrell R Fisher